Page last updated: 2024-08-26

2-propyl-4-pentenoic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

2-propyl-4-pentenoic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blum, W; Byrd, JC; Chan, KK; Cheng, H; Grever, MR; Klisovic, R; Liu, Z; Marcucci, G1

Other Studies

1 other study(ies) available for 2-propyl-4-pentenoic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, May-01, Volume: 850, Issue:1-2

    Topics: Chromatography, High Pressure Liquid; Fatty Acids, Monounsaturated; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Valproic Acid

2007